AI English summary of an SEC filing — figures as filed
Newmont completed the sale of CC&V, Musselwhite, and Éléonore in Q1 2025 and completed the sale of Akyem and Porcupine on April 15, 2025 for total pre-tax cash proceeds of $1,088, net of working capital adjustments. For the 3 months ended 2025, a gain of $276 was recognized within (Gain) loss on sale of assets held for sale.
Key points
AI summaryNewmont completed the sale of CC&V, Musselwhite, and Éléonore in Q1 2025 and completed the sale of Akyem and Porcupine on April 15, 2025 for total pre-tax cash proceeds of $1,088, net of working capital adjustments. For the 3 months ended 2025, a gain of $276 was recognized within (Gain) loss on sale of assets held for sale.
The company cited an increase in Sales resulting from higher average realized gold prices, a net gain recognized within (Gain) loss on sale of assets held for sale, and an increase in unrealized gains on the change in fair value of investments and options as factors in the increase in Net income from continuing operations attributable to Newmont stockholders for the 3 months ended March 31, 2025, partially offset by an increase in income tax expense. Income and mining tax expense was $647 for the period, compared to $260 in the prior year.
Newmont said it fully redeemed the 2026 Senior Notes in February 2025 for $957, with a loss on redemption of $13. Interest expense, net of capitalized interest, was $79 for Q1 2025, compared to $93 in the prior year.
The company said the Board of Directors authorized an additional $2 billion stock repurchase program in October 2024, which will expire after 24 months in October 2026. Through the date of filing, Newmont executed and settled total trades of common stock repurchases under the previously authorized programs of $2,001, of which $348 was repurchased during Q1 2025.
Key figures
Quarter ended March 31, 2025
- Revenue
- $5.0B
- Net income
- $1.9B
- EPS
- $1.68
- Operating cash flow
- $2.0B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Completion of Asset Divestitures and Gains and Losses on Divestitures
Newmont completed the sale of CC&V, Musselwhite, and Éléonore in Q1 2025 and completed the sale of Akyem and Porcupine on April 15, 2025 for total pre-tax cash proceeds of $1,088, net of working capital adjustments. For the 3 months ended 2025, a gain of $276 was recognized within (Gain) loss on sale of assets held for sale.
Source · Based on the MD&A text of the filing
Increase in Net Income from Continuing Operations and Income Tax Expense
The company cited an increase in Sales resulting from higher average realized gold prices, a net gain recognized within (Gain) loss on sale of assets held for sale, and an increase in unrealized gains on the change in fair value of investments and options as factors in the increase in Net income from continuing operations attributable to Newmont stockholders for the 3 months ended March 31, 2025, partially offset by an increase in income tax expense. Income and mining tax expense was $647 for the period, compared to $260 in the prior year.
Source · Based on the MD&A text of the filing
Redemption of 2026 Senior Notes and Interest Expense
Newmont said it fully redeemed the 2026 Senior Notes in February 2025 for $957, with a loss on redemption of $13. Interest expense, net of capitalized interest, was $79 for Q1 2025, compared to $93 in the prior year.
Source · Based on the MD&A text of the filing
Authorization and Execution of Share Repurchase Program
The company said the Board of Directors authorized an additional $2 billion stock repurchase program in October 2024, which will expire after 24 months in October 2026. Through the date of filing, Newmont executed and settled total trades of common stock repurchases under the previously authorized programs of $2,001, of which $348 was repurchased during Q1 2025.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…